Kato, J., Shirakami, Y., Ohnishi, M., Mizutani, T., Kubota, M., Sakai, H. ... Shimizu, M. (1899). Suppressive effects of the sodium‑glucose cotransporter 2 inhibitor tofogliflozin on colorectal tumorigenesis in diabetic and obese mice. Oncology Reports, 0, 0-0. https://doi.org/10.3892/or.2019.7357Kato, J., Shirakami, Y., Ohnishi, M., Mizutani, T., Kubota, M., Sakai, H., Ibuka, T., Tanaka, T., Shimizu, M."Suppressive effects of the sodium‑glucose cotransporter 2 inhibitor tofogliflozin on colorectal tumorigenesis in diabetic and obese mice". Oncology Reports 0.0 (1899): 0-0.Kato, J., Shirakami, Y., Ohnishi, M., Mizutani, T., Kubota, M., Sakai, H., Ibuka, T., Tanaka, T., Shimizu, M."Suppressive effects of the sodium‑glucose cotransporter 2 inhibitor tofogliflozin on colorectal tumorigenesis in diabetic and obese mice". Oncology Reports 0, no. 0 (1899): 0-0. https://doi.org/10.3892/or.2019.7357
